α-1-acid glycoprotein as a predictive biomarker for severe neutropenia induced by docetaxel in esophageal carcinoma

被引：0
作者：
Sasaki, Yusuke [1 ]
Kato, Ken [1 ]
Shoji, Hirokazu [1 ]
Iwasa, Satoru [1 ]
Hamaguchi, Tetsuya [1 ]
Boku, Narikazu [1 ]
机构：
[1] Natl Canc Ctr, Gastrointest Oncol Div, Tokyo, Japan
来源：
CANCER SCIENCE | 2018年 / 109卷
关键词：
alpha 1 acid glycoprotein; Docetaxel;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-2249
引用
收藏
页码：692 / 692
页数：1
相关论文
共 25 条
  • [1] Proposal of a Novel Dosing Schedule of Docetaxel by Using α1-Acid Glycoprotein as an Index
    Ozawa, Kazuhiro
    Minami, Hironobu
    Sato, Hitoshi
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2009, 129 (12): : 1565 - 1572
  • [2] An SNP in CYP39A1 is associated with severe neutropenia induced by docetaxel
    Uchiyama, Toshitaka
    Kanno, Hitoshi
    Ishitani, Ken
    Fujii, Hisaichi
    Ohta, Hiroaki
    Matsui, Hideo
    Kamatani, Naoyuki
    Saito, Kayoko
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (06) : 1617 - 1624
  • [3] An SNP in CYP39A1 is associated with severe neutropenia induced by docetaxel
    Toshitaka Uchiyama
    Hitoshi Kanno
    Ken Ishitani
    Hisaichi Fujii
    Hiroaki Ohta
    Hideo Matsui
    Naoyuki Kamatani
    Kayoko Saito
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 1617 - 1624
  • [4] Plasma alpha-1-acid glycoprotein as a potential predictive biomarker for non-haematological adverse events of docetaxel in breast cancer patients
    Jabir, Rafid Salim
    Ho, Gwo Fuang
    Annuar, Muhammad Azrif Bin Ahmad
    Stanslas, Johnson
    BIOMARKERS, 2018, 23 (02) : 142 - 146
  • [5] The effects of advanced age and serum α1-acid glycoprotein on docetaxel unbound exposure and dose-limiting toxicity in cancer patients
    Kenmotsu, Hirotsugu
    Imamura, Chiyo K.
    Ono, Akira
    Omori, Shota
    Nakashima, Kazuhisa
    Wakuda, Kazushige
    Taira, Tetsuhiko
    Naito, Tateaki
    Murakami, Haruyasu
    Takahashi, Toshiaki
    Tanigawara, Yusuke
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 83 (11) : 2416 - 2425
  • [6] Predictive factors for severe and febrile neutropenia during docetaxel chemotherapy for castration-resistant prostate cancer
    Shigeta, Keisuke
    Kosaka, Takeo
    Yazawa, Satoshi
    Yasumizu, Yota
    Mizuno, Ryuichi
    Nagata, Hirohiko
    Shinoda, Kazunobu
    Morita, Shinya
    Miyajima, Akira
    Kikuchi, Eiji
    Nakagawa, Ken
    Hasegawa, Shintaro
    Oya, Mototsugu
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2015, 20 (03) : 605 - 612
  • [7] Predictive factors for severe and febrile neutropenia during docetaxel chemotherapy for castration-resistant prostate cancer
    Keisuke Shigeta
    Takeo Kosaka
    Satoshi Yazawa
    Yota Yasumizu
    Ryuichi Mizuno
    Hirohiko Nagata
    Kazunobu Shinoda
    Shinya Morita
    Akira Miyajima
    Eiji Kikuchi
    Ken Nakagawa
    Shintaro Hasegawa
    Mototsugu Oya
    International Journal of Clinical Oncology, 2015, 20 : 605 - 612
  • [8] Pharmacoethnicity of docetaxel-induced severe neutropenia: integrated analysis of published phase II and III trials
    Yano, Ryoichi
    Konno, Aya
    Watanabe, Kyohei
    Tsukamoto, Hitoshi
    Kayano, Yuichiro
    Ohnaka, Hiroaki
    Goto, Nobuyuki
    Nakamura, Toshiaki
    Masada, Mikio
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2013, 18 (01) : 96 - 104
  • [9] Pharmacoethnicity of docetaxel-induced severe neutropenia: integrated analysis of published phase II and III trials
    Ryoichi Yano
    Aya Konno
    Kyohei Watanabe
    Hitoshi Tsukamoto
    Yuichiro Kayano
    Hiroaki Ohnaka
    Nobuyuki Goto
    Toshiaki Nakamura
    Mikio Masada
    International Journal of Clinical Oncology, 2013, 18 : 96 - 104
  • [10] Targeting β1 integrin restores sensitivity to docetaxel of esophageal squamous cell carcinoma
    Mori, Ryota
    Ishiguro, Hideyuki
    Kuwabara, Yoshiyuki
    Kimura, Masahiro
    Mitsui, Akira
    Tomoda, Keisuke
    Mori, Yoichiro
    Ogawa, Ryo
    Katada, Takeyasu
    Harata, Koshiro
    Fujii, Yoshitaka
    ONCOLOGY REPORTS, 2008, 20 (06) : 1345 - 1351
123